Hydrocephalus Shunt Market Analysis

Hydrocephalus shunt Market Analysis

Based on product, the market is segmented into hydrocephalus valves and hydrocephalus catheters. The hydrocephalus valves segment held the majority of market share in 2023 and is anticipated to grow at CAGR of 3.6% over the coming years.
 

• The majority share of the hydrocephalus valves segment can be attributed to high adoption of adjustable valves as they allow neurosurgeons to customize CSF drainage as per the requirement of individual patients thereby reducing the risk of over drainage-related complications.
   
• Advanced hydrocephalus valves are utilizing cutting-edge technology, including programmable settings and pressure-sensitive mechanisms to enhance their performance. These advanced features have allowed for continuous monitoring and adjustment of cerebrospinal fluid drainage, ultimately enhancing treatment effectiveness and patient outcomes, which is driving the adoption of valves in the market.
   

Based on procedure type, the hydrocephalus shunt market is classified into ventriculoperitoneal, lumboperitoneal, ventriculoatrial, and ventriculopleural. The ventriculoperitoneal segment dominated the market with a revenue of about USD 401.6 million in 2023.
 

• Preference of ventriculoperitoneal shunting procedure due to their higher reliability specifically during the treatment of congenital hydrocephalus, acquired hydrocephalus (such as post-hemorrhagic hydrocephalus), and normal pressure hydrocephalus is driving their adoption in market.
   
• Moreover, ventriculoperitoneal shunting procedures are less invasive than other procedures, resulting in reduced hospital stay and faster recovery time. As a result, it is preferred by patients and medical practitioners.
   
• Ventriculoperitoneal shunting procedures offers reduced risk of revisions in comparison to other surgical procedures, that enhances the long-term effectiveness and durability of ventriculoperitoneal shunting.
   

Based on age group, the hydrocephalus shunt market is classified into pediatric and adult. The pediatric segment secured a share of about 68.7% in 2023 and is anticipated to grow at 3.5% CAGR during the forecast period.
 

• High incidence of congenital hydrocephalus is driving the adoption of hydrocephalus shunt among pediatric patients. Pediatric patients born with congenital hydrocephalus often require prompt intervention, including shunt placement, to manage the condition and prevent neurological damage.
   
• Moreover, pediatric patients require hydrocephalus shunt placement in the early stage of their life, and ongoing management continues throughout childhood and adolescence. Due to longer treatment duration, multiple number of shunt procedures are performed in pediatric patients, contributing to the dominating share of the segment.
   

Based on end-use, the hydrocephalus shunt market is classified into hospitals and ambulatory surgery centers (ASCs). The hospital segment secured a share of about 71.5% in 2023 and is anticipated to grow at 3.2% CAGR during the forecast period.
 

• Hydrocephalus shunt procedures are typically performed as an inpatient procedure, that are preferably carried out in hospitals. Moreover, hospitals also provide outpatient services such as post-operative follow-up, shunt adjustments, and patient monitoring, which contributes to the dominating share of the hospitals segment.
   
• Additionally, hospitals function as centralized healthcare facilities with specialized infrastructure, operating rooms, and medical professionals capable of diagnosing and effectively treating hydrocephalus. Patients diagnosed with hydrocephalus usually undergo initial diagnosis, surgical procedures, postoperative care, and follow-up services across hospitals, contributing to the revenue growth of the segment.
   

North America hydrocephalus shunt market accounted for 40.2% of market share in global market in 2023 and is predicted to reach USD 238.7 million by 2032.
 

• Availability of a sophisticated healthcare infrastructure that includes state-of-the-art hospitals, specialized neurosurgical centers, and access to cutting-edge medical technology in the region is driving the demand for hydrocephalus shunting procedures.  
   
• Moreover, growing awareness towards hydrocephalus shunting procedures through awareness campaigns run by healthcare providers, hospitals, and patient advocacy groups such as the Hydrocephalus Association in the United States and the Hydrocephalus Canada Association, is driving the demand for timely treatment of hydrocephalus, thereby contributing to the revenue growth in North America.
   

The U.S. hydrocephalus shunt market was valued at USD 161.4 million in 2023 and is anticipated to grow at a CAGR of 3.1% over the forecast period.
 

• Increase in healthcare expenditure related to the treatment of hydrocephalus has led the healthcare settings to adopt proactive treatment approach, thereby driving an increase in early diagnosis and surgical treatments.
• Availability of reimbursement and coverage for hydrocephalus shunting procedures in the U.S. is also driving the patients to opt for elective surgical treatments.
   
• Increasing investments in research and development from vendors have led to an increased availability of advanced hydrocephalus shunt products in the country. For instance, according to the ClinicalTrials.gov, as of April 2024, about 77 clinical trial studies were active in the U.S.
   
• Moreover, presence of established healthcare infrastructure together with large number of established vendors in U.S. offering advanced products is contributing towards increasing adoption of hydrocephalus valves and catheters in the country, thereby driving the revenue growth in the market.
   

Germany hydrocephalus shunt market is expected to show significant growth during the forecast period.
 

• With the aging population, the incidence of conditions like normal pressure hydrocephalus (NPH) is increasing in Germany. According to The World Bank statistics, population aged 65 and above in Germany increased from 20% of total population in 2012 to 22% in 2022. As a result, the demand for surgical intervention such as hydrocephalus shunting has increased in the country, fueling the market growth.
   
• Germany’s well developed health system supported by the presence of skilled neurosurgeons, neurologists, and multidisciplinary teams specializing in the diagnosis and treatment of hydrocephalus is further contributing to the increasing number of hydrocephalus shunting procedures, contributing to the market growth.
   

India hydrocephalus shunt market is anticipated to grow remarkably over the coming years.

• Growing investments in India to upgrade its existing healthcare infrastructure, including the expansion of hospitals, neurosurgical centers, and clinics, well equipped to diagnose and treat hydrocephalus, has surged the patient’s accessibility to advanced treatment options for hydrocephalus.
   
• Moreover, rise in healthcare financing, such as health insurance plans and government-backed healthcare initiatives, have made hydrocephalus treatments more cost-effective and within reach for patients in India. This increased affordability and accessibility are encouraging more individuals to promptly seek timely treatment for hydrocephalus.